Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis

BACKGROUND: Treatment-emergent adverse events (TEAEs) that occur close to treatment initiation may negatively affect overall tolerability and adherence. It is important to develop a clear understanding of potential early TEAEs after initiating treatment with cladribine tablets. OBJECTIVE: To identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Jiwon, Walker, Bryan, Giovannoni, Gavin, Jack, Dominic, Dangond, Fernando, Nolting, Axel, Aldridge, Julie, Lebson, Lori A, Leist, Thomas P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283088/
https://www.ncbi.nlm.nih.gov/pubmed/34345436
http://dx.doi.org/10.1177/20552173211024298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283088/
https://www.ncbi.nlm.nih.gov/pubmed/34345436
http://dx.doi.org/10.1177/20552173211024298

Ejemplares similares